TipRanks
Advertisement
Advertisement

PRQR Stock Latest News

ProQR Doses First Participant in Phase 1 Trial of AX-0811 for Cholestatic Liver Diseases
Company AnnouncementsProQR Doses First Participant in Phase 1 Trial of AX-0811 for Cholestatic Liver Diseases
10d ago
6K
PRQR
ProQR Therapeutics doses first participant in AX-0811 clinical trial
PremiumThe Fly
ProQR Therapeutics doses first participant in AX-0811 clinical trial
10d ago
PRQR
KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts
PremiumWeekend Updates
KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts
28d ago
KDP
AUPH
ProQR Therapeutics initiated with a Buy at BofA
PremiumThe Fly
ProQR Therapeutics initiated with a Buy at BofA
30d ago
PRQR
ProQR posts Q2 2026 results as Axiomer RNA editing gains first clinical validation
PremiumCompany Announcements
ProQR posts Q2 2026 results as Axiomer RNA editing gains first clinical validation
1M ago
6K
PRQR
ProQR Reports Higher Revenue but Ongoing Losses in Second Quarter 2026 Results
PremiumCompany AnnouncementsProQR Reports Higher Revenue but Ongoing Losses in Second Quarter 2026 Results
1M ago
6K
PRQR
ProQR Therapeutics BV (PRQR) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
ProQR Therapeutics BV (PRQR) Q2 Earnings Cheat Sheet
2M ago
PRQR
Insider Shake-Up: Paychex, ASE, Verisign, ProQR, Pagseguro
Premium
Weekend Updates
Insider Shake-Up: Paychex, ASE, Verisign, ProQR, Pagseguro
2M ago
ASX
PAGS
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
PremiumWeekend Updates
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
2M ago
ASX
YPF
ProQR Therapeutics registers to sell 3.03M ordinary shares for holders
PremiumThe Fly
ProQR Therapeutics registers to sell 3.03M ordinary shares for holders
2M ago
PRQR
ProQR Therapeutics price target lowered to $10 from $14 at Raymond James
PremiumThe Fly
ProQR Therapeutics price target lowered to $10 from $14 at Raymond James
3M ago
PRQR
ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
PremiumCompany Announcements
ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
3M ago
6K
PRQR
ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
PremiumThe FlyProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
3M ago
PRQR
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
Premium
The Fly
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
3M ago
PRQR
ProQR Reports Positive Phase 1 Data Validating Axiomer RNA Editing Platform
Premium
Company Announcements
ProQR Reports Positive Phase 1 Data Validating Axiomer RNA Editing Platform
3M ago
6K
PRQR
ProQR Therapeutics prices 27.62M shares at $1.81 in registered direct offering
PremiumThe Fly
ProQR Therapeutics prices 27.62M shares at $1.81 in registered direct offering
3M ago
LLY
PRQR
ProQR Therapeutics announces positive Phase 1 data for AX-0810
PremiumThe Fly
ProQR Therapeutics announces positive Phase 1 data for AX-0810
3M ago
PRQR
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
PremiumCompany Announcements
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
4M ago
6K
PRQR
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
PremiumRatings
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
4M ago
PRQR
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
PremiumCompany AnnouncementsProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
4M ago
6K
PRQR
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
Premium
Company Announcements
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
4M ago
6K
PRQR
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
Premium
Company Announcements
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
5M ago
6K
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >